SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/19/2019
Entire Document
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 19, 2019

 

     
PERNIX THERAPEUTICS HOLDINGS, INC.
   
By:  

/s/ John A. Sedor 

Name:   John A. Sedor
Title:   Chief Executive Officer